SG heads into its next earnings cycle on June 11 with a contradictory setup: a 23% price rally over the past month, short sellers slowly unwinding, and the Street barely able to bring itself to say buy.
Short interest remains uncomfortably high at roughly 22% of free float — down from a peak near 26% at the start of April, but still far above levels a recovering growth story would attract. The month-long unwind has been steady rather than violent, which tells a different story than a squeeze. Availability in the lending market has loosened alongside the covering; borrow costs have also eased to about 0.57%, well below the 0.75% range seen in early April. The ORTEX short score holds at 66.8 out of 100, ranking SG in the bottom 11th percentile of the universe — a signal that short interest remains structurally elevated even as the raw share count drifts lower.
Options traders are also tilting bullish, but in a muted way. The put/call ratio has slipped to 0.34, around 1.4 standard deviations below its 20-day average of 0.37 — the lowest level of the past year. That kind of call-heavy skew typically reflects momentum chasers rather than conviction holders, and the reading sits right at the 52-week floor. The combination of a fading short base and a call-heavy options book is consistent with a short-term squeeze recovery rather than a fundamental re-rating.
The Street is exactly where you'd expect it to be: agnostic and raising numbers slowly. Following the May 7 earnings print, UBS raised its target from $6.50 to $7.00 while holding at Neutral, and TD Cowen moved from $5.00 to $7.00 on a Hold. Both now sit precisely at the current stock price, implying no upside from here at these two firms. BNP Paribas, the firmest bear on the list, lifted its Underperform target from $4.50 to $5.00 — still 29% below where the stock closed. Citi holds the lone Buy, with a $9.00 target. The mean target of $7.00 also aligns exactly with Thursday's close, which makes the consensus position arithmetically neutral. The bull case rests on a long-runway restaurant growth story: 15-20% net new unit expansion through 2027 and a track record of strong same-store sales in maturing cohorts. The bear case is blunter — flat same-store sales guidance for 2025, with Bloomberg Second Measure and Placer.ai data pointing to persistent traffic weakness. The EV/EBITDA multiple, while compressing 19 points over the past 30 days, still prints above 132x, pricing in a significant recovery that has yet to appear in the numbers.
Goldman Sachs deserves a separate note, though it reads more mechanical than strategic. The firm disclosed a series of small purchases on April 7 totalling roughly 16,000 shares at prices around $5.66-5.70. That pushed Goldman to a 9.7% stake in the company — the largest disclosed institutional holding. These look like passive or derivatives-related accumulation rather than a directional call, particularly given the tiny lot sizes and Goldman's status as a listed 10% owner. Net insider-affiliated buying over 90 days runs to about 595,000 shares at a net value of $3.4 million, but the bulk reflects Goldman's own filings rather than operational management buying from inside the business.
CAVA, the closest fast-casual peer by correlation, had a rougher week — down 12.7% — while CMG lost about 1.5%. SG's relative resilience on the week, falling less than 1.5%, suggests some of the recent short covering has been supporting the tape. SHAK was the outlier in the other direction, shedding nearly 29% following its own earnings. The June 11 print is now the fulcrum: whether Sweetgreen can show enough traffic momentum to justify a price-to-nothing target consensus — and whether the remaining 22% short base decides to wait around to find out.
See the live data behind this article on ORTEX.
Open SG on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
